Clinical Trials Search at Vanderbilt-Ingram Cancer Center
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Multiple Cancer Types
The main purpose of this study is to evaluate safety and efficacy in participants treated with concomitant chemoradiation therapy (cCRT) plus M7824 followed by M7824 compared to cCRT plus placebo followed by durvalumab.
Lung,
Non Small Cell
II
Osmundson, Evan
NCT03840902
VICCTHO1917
